King Pharmaceuticals Financial Statements
King Pharmaceuticals Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
King Pharmaceuticals Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 2,136.9 | 1,988.5 | 1,772.9 |
| Gross Profit ($ mil.) | 1,570.3 | 1,568.7 | 1,449.9 |
| Operating Income ($ mil.) | 227.5 | 402.5 | 180.1 |
| Total Net Income ($ mil.) | 183.0 | 289.0 | 117.8 |
| Diluted EPS (Net Income) | 0.75 | 1.19 | 0.49 |
King Pharmaceuticals Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 396.9 | 432.0 | 533.3 |
| Gross Profit ($ mil.) | 294.7 | 340.6 | 401.5 |
| Operating Income ($ mil.) | 57.8 | 121.4 | 49.5 |
| Total Net Income ($ mil.) | 43.0 | 87.6 | 42.8 |
| Diluted EPS (Net Income) | 0.17 | 0.36 | 0.18 |
King Pharmaceuticals Stock Quote & Chart
10/07/08 15:06:28 EST •
NYSE •
8.21
•
 0.0000
•
0.0000 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
King Pharmaceuticals Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 1.39 | 3.32 | 1.48 |
| Price/Earnings Ratio | 19.53 | 14.77 | 15.35 |
| Price/Book Ratio | 1.00 | 2.73 | 1.44 |
| Price/Cash Flow Ratio | 4.02 | 12.22 | 9.34 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed King Pharmaceuticals Financial Ratios
King Pharmaceuticals Competitive Intelligence
| Elan | Hospira | Wyeth | |
|---|---|---|---|
| Annual Sales ($ mil.) | 759.4 | 3,436.2 | 22,399.8 |
| Employees | -- | 14,000 | 50,527 |
| Market Cap ($ mil.) | -- | 6,305.9 | 53,137.3 |
Competitive Landscape
